• We are sorry, but NCBI web applications do not support your browser and may not function properly. More information

Table 4Strength of evidence for metoclopramide versus placebo

ComparisonOutcome (N Studies; N Patients)Strength of Evidence DomainsStrength of Evidence
Metoclopramide monotherapy vs. placeboPain intensity–VAS (5; 328)ModerateConsistentDirectPreciseModerate
Headache relief (1; 50)ModerateUnknownDirectPreciseInsufficient
Headache recurrence (1; 77)LowUnknownDirectImpreciseInsufficient
Metoclopramide+ DHE or dexamethasone vs. placeboPain improvement (1 RCT [3 arms]; 20)ModerateUnknownDirectPreciseInsufficient

DHE = dihydroergotamine; N = number; ROB = risk of bias; RCT = randomized control trial; VAS = visual analogue scale

From: Results

Cover of Acute Migraine Treatment in Emergency Settings
Acute Migraine Treatment in Emergency Settings [Internet].
Comparative Effectiveness Reviews, No. 84.
Sumamo Schellenberg E, Dryden DM, Pasichnyk D, et al.

PubMed Health. A service of the National Library of Medicine, National Institutes of Health.